Dapagliflozin Mechanism, Therapeutic Role, and Clinical Applications in Diabetes, Heart Failure, and Kidney Disease

Innovative Research Journals

Dapagliflozin Mechanism, Therapeutic Role, and Clinical Applications in Diabetes, Heart Failure, and Kidney Disease Introduction Dapagliflozin is an oral medication classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor, developed initially for the treatment of type 2 diabetes mellitus (T2DM). Its benefits, however, […]

Read More